These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 23281268)
1. Safety and efficacy of high-dose tamoxifen and sulindac for desmoid tumor in children: results of a Children's Oncology Group (COG) phase II study. Skapek SX; Anderson JR; Hill DA; Henry D; Spunt SL; Meyer W; Kao S; Hoffer FA; Grier HE; Hawkins DS; Raney RB Pediatr Blood Cancer; 2013 Jul; 60(7):1108-12. PubMed ID: 23281268 [TBL] [Abstract][Full Text] [Related]
2. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Hansmann A; Adolph C; Vogel T; Unger A; Moeslein G Cancer; 2004 Feb; 100(3):612-20. PubMed ID: 14745880 [TBL] [Abstract][Full Text] [Related]
3. High-dose tamoxifen and sulindac as first-line treatment for desmoid tumors. Sturt NJ; Phillips RK; Clark SK Cancer; 2004 Aug; 101(3):652; author reply 653. PubMed ID: 15274082 [No Abstract] [Full Text] [Related]
4. Vinblastine and methotrexate for desmoid fibromatosis in children: results of a Pediatric Oncology Group Phase II Trial. Skapek SX; Ferguson WS; Granowetter L; Devidas M; Perez-Atayde AR; Dehner LP; Hoffer FA; Speights R; Gebhardt MC; Dahl GV; Grier HE; J Clin Oncol; 2007 Feb; 25(5):501-6. PubMed ID: 17290057 [TBL] [Abstract][Full Text] [Related]
5. Pazopanib therapy for desmoid tumors in adolescent and young adult patients. Agresta L; Kim H; Turpin BK; Nagarajan R; Plemmons A; Szabo S; Dasgupta R; Sorger JI; Pressey JG Pediatr Blood Cancer; 2018 Jun; 65(6):e26968. PubMed ID: 29384266 [TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients. Quast DR; Schneider R; Burdzik E; Hoppe S; Möslein G Fam Cancer; 2016 Jan; 15(1):31-40. PubMed ID: 26275868 [TBL] [Abstract][Full Text] [Related]
7. Multimodal treatment of children with unresectable or recurrent desmoid tumors: an 11-year longitudinal observational study. Lackner H; Urban C; Benesch M; Raith J; Moser A; Sovinz P; Schwinger W; Dornbusch HJ; Triebl-Roth K J Pediatr Hematol Oncol; 2004 Aug; 26(8):518-22. PubMed ID: 15284591 [TBL] [Abstract][Full Text] [Related]
8. Aggressive fibromatosis in children and adolescents: the Italian experience. Meazza C; Bisogno G; Gronchi A; Fiore M; Cecchetto G; Alaggio R; Milano GM; Casanova M; Carli M; Ferrari A Cancer; 2010 Jan; 116(1):233-40. PubMed ID: 19950127 [TBL] [Abstract][Full Text] [Related]
9. Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study. Toulmonde M; Pulido M; Ray-Coquard I; Andre T; Isambert N; Chevreau C; Penel N; Bompas E; Saada E; Bertucci F; Lebbe C; Le Cesne A; Soulie P; Piperno-Neumann S; Sweet S; Cecchi F; Hembrough T; Bellera C; Kind M; Crombe A; Lucchesi C; Le Loarer F; Blay JY; Italiano A Lancet Oncol; 2019 Sep; 20(9):1263-1272. PubMed ID: 31331699 [TBL] [Abstract][Full Text] [Related]
10. Low-dose dacarbazine-doxorubicin therapy against intra-abdominal desmoid tumors. Yamamoto H; Oshiro R; Nishimura J; Uemura M; Haraguchi N; Hata T; Takemasa I; Mizushima T; Sekimoto M; Doki Y; Mori M Oncol Rep; 2013 May; 29(5):1751-5. PubMed ID: 23503528 [TBL] [Abstract][Full Text] [Related]
11. Pharmacologic treatment of desmoid tumors in familial adenomatous polyposis: results of an in vitro study. Tonelli F; Valanzano R; Brandi ML Surgery; 1994 Apr; 115(4):473-9. PubMed ID: 8165538 [TBL] [Abstract][Full Text] [Related]
12. Chemotherapy in patients with desmoid tumors: a study from the French Sarcoma Group (FSG). Garbay D; Le Cesne A; Penel N; Chevreau C; Marec-Berard P; Blay JY; Debled M; Isambert N; Thyss A; Bompas E; Collard O; Salas S; Coindre JM; Bui B; Italiano A Ann Oncol; 2012 Jan; 23(1):182-186. PubMed ID: 21444357 [TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy using vinblastine and methotrexate for the treatment of progressive desmoid tumor in children. Skapek SX; Hawk BJ; Hoffer FA; Dahl GV; Granowetter L; Gebhardt MC; Ferguson WS; Grier HE J Clin Oncol; 1998 Sep; 16(9):3021-7. PubMed ID: 9738571 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in India. Bajpai J; Munot P; Kota K; Gupta G; Gala K; Gulia A; Rekhi B; Khanna N; Shetty N; Bhargava P; Srinivas S; Ostwal V; Patil V; Noronha V; Kulkarni S; Laskar S; Prabhash K; Chinnaswamy G; Gupta S; Banavali S JCO Glob Oncol; 2024 May; 10():e2300308. PubMed ID: 38723218 [TBL] [Abstract][Full Text] [Related]
15. Regression of large pelvic desmoid tumor by tamoxifen and sulindac. Izes JK; Zinman LN; Larsen CR Urology; 1996 May; 47(5):756-9. PubMed ID: 8650880 [TBL] [Abstract][Full Text] [Related]
17. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI. Ingley KM; Burtenshaw SM; Theobalds NC; White LM; Blackstein ME; Gladdy RA; Thipphavong S; Gupta AA Cancer Med; 2019 Sep; 8(11):5047-5057. PubMed ID: 31301110 [TBL] [Abstract][Full Text] [Related]
18. [Low-dose methotrexate combined with vinorelbine for inoperable desmoid tumor: efficacy and the prognostic factors]. Fan Z; Li S; Fang Z; Liu J; Bai C; Xue R; Zhang L; Gao T Nan Fang Yi Ke Da Xue Xue Bao; 2016 Jan; 36(1):39-43. PubMed ID: 26806736 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of apatinib for patients with advanced extremity desmoid fibromatosis: a retrospective study. Zheng C; Fang J; Wang Y; Zhou Y; Tu C; Min L J Cancer Res Clin Oncol; 2021 Jul; 147(7):2127-2135. PubMed ID: 33452581 [TBL] [Abstract][Full Text] [Related]
20. Oral vinorelbine in young patients with desmoid-type fibromatosis. Kornreich L; Orbach D; Nicolas N; Brisse HJ; Berlanga P; Defachelles AS; Mansuy L; Verite C; Saumet L; Karanian M; Corradini N Tumori; 2023 Oct; 109(5):511-518. PubMed ID: 37114926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]